Congenital chronic diarrhea with protein-losing enteropathy is not usually one single disease name. It is a clinical description for a baby or young child who has diarrhea that starts very early in life, lasts a long time, and causes the body to lose important blood proteins into the gut. Because protein is lost into the intestine, the child may develop low albumin, swelling, poor weight gain, weakness, and malnutrition. Doctors usually place this problem inside the broader group called congenital diarrheas and enteropathies or congenital enteropathies.
Congenital chronic diarrhea with protein-losing enteropathy is not usually one single disease. It is a clinical pattern seen in some rare congenital diarrheas and enteropathies, where a baby or child has long-lasting diarrhea from early life and also loses body protein through the intestine. This can lead to low albumin, swelling, poor weight gain, dehydration, vitamin deficiency, weak immunity, and growth failure. Reviews of congenital diarrheal disorders explain that treatment is usually supportive and cause-based, because many patients have different gene defects or different forms of intestinal injury. Recent reviews also note that nutrition is the cornerstone of care, and some children need long-term specialized formula or even parenteral nutrition.
Other names
Other names used for this problem can include congenital protein-losing enteropathy, early-onset protein-losing enteropathy, infantile protein-losing enteropathy, congenital enteropathy with protein loss, and sometimes congenital diarrhea and enteropathy with hypoalbuminemia. In some children, the final diagnosis turns out to be a named rare disease such as DGAT1 deficiency, CHAPLE syndrome due to CD55 deficiency, or primary intestinal lymphangiectasia.
Types
Type 1 is lymphatic-loss type. In this type, abnormal or blocked intestinal lymph vessels leak lymph, fats, immune cells, and proteins into the bowel. A classic example is primary intestinal lymphangiectasia, also called Waldmann disease.
Type 2 is epithelial barrier or mucosal injury type. Here, the inner lining of the intestine is damaged or built abnormally, so proteins escape through the bowel wall. Disorders such as congenital tufting enteropathy and some inflammatory monogenic enteropathies fit here.
Type 3 is lipid-transport or metabolic type. In this group, the intestine cannot handle fats normally, and that can lead to severe diarrhea, malabsorption, and protein loss. DGAT1 deficiency is the best known example.
Type 4 is immune-inflammatory type. In this type, immune dysregulation causes bowel inflammation and protein leakage. Examples include CD55 deficiency, IL10 pathway defects, XIAP-related disease, and other forms of monogenic very-early-onset inflammatory bowel disease.
Type 5 is syndromic type. In this type, diarrhea and protein loss happen together with problems in other body systems such as skin, hair, liver, blood vessels, joints, or the immune system. Examples include trichohepatoenteric syndrome and infantile systemic hyalinosis.
Causes
- Primary intestinal lymphangiectasia is a congenital lymphatic disorder in which intestinal lymph channels are enlarged and leaky, causing protein loss, swelling, diarrhea, and low lymphocyte counts.
- DGAT1 deficiency is a rare inherited fat-processing disorder that can cause early watery diarrhea, hypoalbuminemia, and protein-losing enteropathy in infancy.
- CD55 deficiency (CHAPLE syndrome) causes complement overactivity, early diarrhea, severe protein-losing enteropathy, lymphangiectasia, edema, and risk of blood clots.
- Congenital tufting enteropathy is a congenital enterocyte disorder caused mainly by EPCAM or SPINT2 defects and leads to severe chronic watery diarrhea and poor growth from early life.
- Microvillus inclusion disease is a severe congenital epithelial trafficking disorder that causes intractable neonatal diarrhea and intestinal failure, and may be part of the differential diagnosis when a baby has early diarrhea with malnutrition.
- Trichohepatoenteric syndrome causes chronic diarrhea in infancy along with hair changes, facial features, immune problems, and failure to thrive.
- Infantile systemic hyalinosis / hyaline fibromatosis syndrome can cause persistent diarrhea with protein-losing enteropathy because abnormal hyaline material collects in many organs.
- PLVAP deficiency is a very rare genetic cause of severe congenital protein-losing enteropathy due to endothelial barrier failure.
- TTC7A deficiency can cause severe congenital enteropathy or very-early-onset inflammatory bowel disease with chronic diarrhea, villous atrophy, and major intestinal disease.
- IL10 deficiency can lead to severe inflammatory bowel disease in infancy with enterocolitis, diarrhea, and major bowel inflammation.
- IL10RA deficiency causes loss of IL-10 signaling and may present in the first months of life with severe enterocolitis and chronic diarrhea.
- IL10RB deficiency is another IL-10 pathway defect that can produce a similar severe infantile inflammatory bowel picture.
- XIAP deficiency may cause very-early-onset inflammatory bowel disease with chronic colitis and severe intestinal inflammation.
- IPEX syndrome can cause severe early enteropathy and large-volume diarrhea due to immune dysregulation.
- Autoimmune enteropathy of infancy can damage the bowel lining, producing chronic diarrhea and protein loss.
- Congenital sodium diarrhea is a transport disorder that causes severe early diarrhea and major fluid loss; it is part of the congenital diarrhea group that must be considered during diagnosis.
- Congenital chloride diarrhea is another inherited transport defect causing chronic watery diarrhea from early life and important electrolyte loss.
- Glucose-galactose malabsorption is a congenital transporter defect that causes severe neonatal osmotic diarrhea and dehydration after feeding.
- Enteroendocrine cell disorders such as neurogenin-3–related disease can cause congenital malabsorptive diarrhea and failure to thrive.
- Other monogenic very-early-onset inflammatory bowel diseases can present in infancy with chronic diarrhea, malnutrition, bowel inflammation, and sometimes protein-losing enteropathy.
Symptoms
- Chronic diarrhea is the main symptom. The stool may be frequent, watery, bulky, or sometimes fatty depending on the exact cause.
- Diarrhea beginning very early in life is an important clue. Many congenital forms start in the newborn period or within the first months after birth.
- Poor weight gain happens because the child loses nutrients, water, and proteins and cannot absorb food well.
- Failure to thrive means the baby does not grow as expected in weight and sometimes in length and head growth too.
- Swelling of the legs, feet, eyelids, or face can happen when albumin becomes low from protein loss into the gut.
- Ascites, which means fluid in the abdomen, may appear in more severe protein loss.
- Pleural effusion, meaning fluid around the lungs, can happen especially in intestinal lymphangiectasia and severe hypoalbuminemia.
- Vomiting may occur in some congenital diarrheal disorders, especially during feeding intolerance.
- Dehydration is common because the child loses a lot of water and salts in the stool.
- Electrolyte imbalance may cause weakness, lethargy, irritability, or even heart rhythm problems in severe cases.
- Abdominal distension or bloating can happen when the intestine is inflamed, malabsorbing, or filled with fluid or gas.
- Abdominal pain may be present, especially in inflammatory or lymphatic disorders.
- Fatty stool or steatorrhea may happen when fat absorption is poor, such as in DGAT1-related disease or lymphatic disorders.
- Repeated infections may occur because some children also lose immunoglobulins and lymphocytes or have a primary immune defect.
- Signs outside the gut such as hair changes, skin lesions, liver disease, joint problems, or perianal disease may point to a syndromic or immune cause.
Diagnostic tests
Physical exam tests:
- Growth measurement checks weight, length or height, and head growth. Slow growth strongly supports a chronic intestinal disease.
- Dehydration exam looks for dry mouth, sunken eyes, low tears, fast pulse, and poor skin turgor. This helps judge how much fluid the child has lost.
- Edema exam looks for swelling in the feet, legs, face, or eyelids. This is a key clue for low albumin from protein loss.
- Nutrition exam checks muscle wasting, loss of fat stores, weakness, and signs of vitamin deficiency. This helps show how much malabsorption has affected the child.
Manual tests:
- Abdominal palpation helps detect distension, tenderness, organ enlargement, or fluid. It is simple but useful at the bedside.
- Percussion for ascites helps the doctor look for free fluid in the abdomen, which can occur with severe hypoalbuminemia.
- Pitting edema test means the doctor presses on swollen skin to see if a pit remains. This supports fluid retention from low plasma protein.
- Perianal inspection and rectal exam when needed may help detect fissures, fistulas, irritation, or bleeding, especially when inflammatory bowel disease is suspected.
Lab and pathological tests:
- Serum albumin is one of the most important tests because low albumin is a major sign of protein-losing enteropathy.
- Total serum protein helps measure the overall fall in blood proteins.
- Serum immunoglobulins, especially IgG may be low when proteins are leaking through the gut.
- Complete blood count can show anemia, infection clues, lymphopenia, or other immune and nutrition problems.
- Electrolyte panel checks sodium, potassium, chloride, bicarbonate, calcium, and magnesium because chronic diarrhea often disturbs body salts.
- Stool alpha-1 antitrypsin is a key screening test because high stool levels suggest protein is leaking into the intestine.
- Alpha-1 antitrypsin clearance using serum and 24-hour stool testing is a major confirmatory test for protein-losing enteropathy.
- Stool pH and reducing substances help look for carbohydrate malabsorption and can guide the congenital diarrhea workup.
- Fecal fat testing helps detect fat malabsorption, which may be important in DGAT1 deficiency and lymphatic disease.
- Small-bowel endoscopy with biopsy is very important because it can show villous atrophy, epithelial tufts, lymphangiectasia, inflammation, or inclusion-type changes.
- Genetic testing is now central in congenital diarrhea because many causes are monogenic, including DGAT1, EPCAM, SPINT2, CD55, TTC7A, and others.
Electrodiagnostic and imaging-related tests:
- Electrocardiogram and abdominal imaging are not the main tests for diagnosis, but they are often helpful. ECG can look for effects of major electrolyte imbalance, and ultrasound, MR lymphangiography, capsule endoscopy, or other imaging can help detect ascites, bowel changes, or abnormal intestinal lymphatics, especially in intestinal lymphangiectasia.
Non-pharmacological treatments
- Rapid rehydration and careful fluid replacement help replace the water and salts lost in stool. This supports blood flow, kidney function, and general stability. The mechanism is simple: diarrhea removes fluid and electrolytes, so the body must receive them back in a safe, measured way.
- Specialized oral or tube feeding is one of the most important treatments. Reviews of congenital enteropathies say specialized formula, restrictive diet, or enteral nutrition often reduces stool burden and supports growth. The mechanism is that the gut may tolerate certain nutrient forms better than others.
- High-protein nutrition is often needed because protein is being lost into the gut. This helps rebuild albumin and body tissues. In protein-losing enteropathy, maintaining nutrition and increasing protein intake are core parts of treatment.
- Low-fat diet with medium-chain triglycerides is especially helpful when the protein loss is linked to intestinal lymphatic disease. Reviews explain that reducing long-chain fat lowers lymph flow and leakage, while medium-chain triglycerides are absorbed more directly.
- Elemental or amino-acid formula may help when whole proteins are poorly tolerated. The purpose is to reduce digestive stress and improve absorption. The mechanism is that nutrients are given in a simpler form that may be easier for a damaged intestine to handle.
- Extensively hydrolyzed formula can be useful in selected infants, especially when there is overlap with food-protein intolerance. It gives protein in smaller fragments, which may improve tolerance and reduce symptoms in some patients.
- Temporary bowel rest with parenteral nutrition is sometimes required in severe disease. Reviews on congenital enteropathies state that some children need prolonged or indefinite parenteral nutrition when enteral tolerance is poor. The mechanism is to bypass the damaged bowel and provide calories, protein, fats, vitamins, and minerals directly into the bloodstream.
- Parenteral nutrition line care and infection prevention are essential if long-term intravenous feeding is used. This is not just support; it prevents catheter sepsis, liver injury, and treatment failure.
- Albumin monitoring with nutrition-guided correction helps track severity. The purpose is to catch falling protein early before swelling, breathing problems, or poor healing become severe.
- Fat-soluble vitamin replacement by diet plan is important because chronic diarrhea and fat malabsorption can lower vitamins A, D, E, and K. Reviews of protein-losing enteropathy specifically mention vitamin support as part of care.
- Micronutrient surveillance for zinc, magnesium, iron, folate, selenium, and vitamin B12 is needed because chronic intestinal loss and poor absorption can cause many deficiencies. This helps growth, immunity, and healing.
- Growth monitoring with weight, length or height, and head circumference in infants is a treatment tool, not only a test. It shows whether the nutrition plan is truly working.
- Stool-volume tracking helps families and clinicians see whether a formula change or treatment is helping. The mechanism is practical: objective stool data guide treatment adjustment.
- Edema management with limb elevation and skin care helps comfort when albumin is low and swelling is present. It does not fix the cause, but it reduces skin breakdown and discomfort.
- Cause-specific elimination diets may help selected patients, such as carbohydrate restriction in defined transport defects or fat restriction in DGAT1-related disease. Reviews stress that nutrition must match the molecular cause whenever possible.
- Genetic counseling and family testing are valuable because many congenital diarrheas are monogenic. This helps diagnosis, future pregnancy planning, and sometimes treatment choice.
- Multidisciplinary intestinal rehabilitation care often gives the best long-term outcome. These teams usually include pediatric gastroenterology, nutrition, genetics, surgery, pharmacy, and nursing.
- Vaccination review and infection prevention matter because protein-losing enteropathy can lower immunoglobulins and lymphocytes, making infections more dangerous.
- Home feeding education for caregivers is essential. Families need clear instructions about formula mixing, tube feeds, stool warning signs, and dehydration signs. This reduces hospital admission and feeding errors.
- Long-term follow-up for liver, bone, and developmental health is needed in severe chronic cases, especially when parenteral nutrition is used for a long time. The goal is to reduce long-term complications while supporting normal development.
Drug treatments used in selected patients
These medicines are not all routine for every patient. They are examples of FDA-labeled drugs or standard medical drugs that may be used for the underlying cause, complications, or intestinal failure context, always under specialist care.
- Octreotide is a somatostatin analog. It may reduce intestinal secretion and can help selected cases of severe diarrhea or lymphatic leakage. Label-based dosing is individualized; in children, specialist weight-based dosing is used. Important side effects include gallbladder problems, glucose changes, and thyroid effects.
- Teduglutide is a GLP-2 analog approved for short bowel syndrome patients who need parenteral support. It is not a cure for congenital PLE, but in intestinal failure settings it can improve absorption and reduce parenteral nutrition dependence. The FDA label lists 0.05 mg/kg once daily by subcutaneous injection.
- Prednisolone is a corticosteroid used when there is inflammatory or immune-mediated enteropathy. Dose is individualized by age and disease. Side effects include infection risk, high blood sugar, mood change, poor growth with long use, and adrenal suppression.
- Budesonide is a corticosteroid with more local gut effect in selected intestinal inflammatory conditions. Some labeled products use 9 mg daily in older patients for approved indications, but congenital enteropathy use is cause-specific and specialist-directed.
- Loperamide is an anti-diarrheal that slows bowel movement. It can reduce stool frequency in selected older children or adults, but it is not appropriate for every infant and should never be used casually in severe illness. The FDA OTC labels show common doses such as 2 mg per dose in older patients.
- Cholestyramine may help when bile-acid-related diarrhea is part of the problem. Each packet commonly contains 4 g cholestyramine resin. It can cause bloating and can reduce absorption of other drugs and vitamins.
- Pancrelipase is useful only if pancreatic insufficiency is present. FDA labeling supports its use in pediatric and adult exocrine pancreatic insufficiency. It improves fat and protein digestion and may reduce diarrhea and malnutrition in that subgroup.
- Metronidazole can be used when bacterial overgrowth or specific infection is suspected. It is not a routine treatment for all congenital diarrhea. Side effects can include nausea, metallic taste, and neuropathy with prolonged use.
- Rifaximin is a poorly absorbed antibiotic sometimes used for bacterial overgrowth or gut flora-related symptoms in selected patients. It is not effective for every diarrhea type.
- Intravenous albumin is sometimes used in severe hypoalbuminemia with edema or instability. It raises plasma oncotic pressure for a short time, but the effect may not last unless the intestinal protein loss is controlled.
- Electrolyte replacement medicines such as potassium, magnesium, sodium bicarbonate, or phosphate may be needed when stool loss is heavy. They do not cure the disease, but they prevent dangerous complications.
- Vitamin K may be needed when fat malabsorption lowers clotting factor production. This can reduce bleeding risk in deficient patients.
- Vitamin D preparations may be required to protect bone health in chronic malabsorption. This is especially important in children with poor fat absorption or long-term nutrition problems.
- Iron therapy may be used if chronic disease or intestinal loss leads to iron deficiency anemia. The purpose is to improve oxygen delivery and growth.
- Folate or vitamin B12 replacement is used if deficiency is found. This supports blood formation, growth, and nerve health.
- Zinc therapy is often useful in chronic diarrhea because zinc loss can worsen diarrhea and poor healing. This is supportive, not disease-curing.
- Diuretics may be used very carefully for severe edema or effusions, but only after volume status is checked because dehydration can worsen.
- Acid suppression medicines may sometimes be used with pancreatic enzymes or for reflux-related feeding discomfort, but they are not direct PLE treatment.
- Immunosuppressive medicines may be needed in autoimmune or inflammatory enteropathy, but the exact drug depends on the diagnosis. Steroids are usually the first example, and other agents are specialist chosen.
- Antimicrobials for proven infection are sometimes necessary because protein-losing enteropathy can be worsened by intestinal infections and immunoglobulin loss may raise infection risk. The exact drug must match the organism.
Dietary molecular supplements
- Medium-chain triglyceride oil is one of the most important supportive nutrition tools in lymphatic or fat-malabsorption forms. It gives calories while lowering long-chain fat load.
- Zinc helps gut repair, immunity, and enzyme function. Chronic diarrhea can lower zinc, and replacement may improve recovery when deficiency exists.
- Vitamin D supports bones and immunity, especially in chronic malabsorption.
- Vitamin A supports vision, epithelial healing, and immune function, and may need replacement if fat absorption is poor.
- Vitamin E may be needed in chronic fat malabsorption because deficiency can affect nerves and red blood cells.
- Vitamin K supports blood clotting and may be low when fat absorption is poor.
- Iron may be needed when anemia develops from malnutrition or chronic disease.
- Folate supports cell division and growth in rapidly growing infants and children.
- Vitamin B12 is useful when deficiency is proven, especially if small bowel disease affects absorption.
- Selenium or magnesium replacement may be required in severe long-term diarrhea or prolonged parenteral nutrition. These support enzyme systems, heart rhythm, and muscle function.
Advanced or special-use drugs
There are no established FDA-approved “immunity booster,” “stem cell,” or “regenerative” drugs specifically for congenital chronic diarrhea with protein-losing enteropathy as a whole. In real practice, advanced treatment usually means intestinal rehabilitation, cause-specific immunotherapy, teduglutide in intestinal failure, or transplantation, not routine “booster” medicines.
- Teduglutide is the clearest advanced medicine when the child has short bowel syndrome with parenteral nutrition dependence.
- Octreotide may act as an advanced supportive option in selected refractory secretory or lymphatic cases.
- Prednisolone can be an advanced immune-directed medicine when the cause is autoimmune enteropathy.
- Budesonide may be used as a more gut-targeted steroid option in selected inflammatory disorders.
- Cause-specific biologic or immunosuppressive therapy may be considered by specialists in immune dysregulation enteropathies, but evidence is diagnosis-specific rather than syndrome-wide.
- Parenteral nutrition support medicines and line-related supportive drugs are often part of advanced intestinal failure care even though they are not disease-curing.
Surgeries or procedures
- Central venous catheter placement is often necessary for long-term parenteral nutrition. It is done when the child cannot absorb enough nutrition safely through the gut.
- Endoscopy with biopsy is not a curative surgery, but it is a major procedure used to define the cause. It helps show villous injury, lymphangiectasia, inflammation, or specific congenital patterns.
- Feeding gastrostomy or jejunostomy may be used when long-term enteral nutrition is needed and oral feeding is not enough or is unsafe.
- Surgery for a structural bowel problem may be needed if the underlying diagnosis includes obstruction, malrotation, or another anatomical cause contributing to diarrhea and poor absorption.
- Intestinal transplant or combined liver-intestinal transplant is reserved for the most severe intestinal failure cases with life-threatening complications of long-term parenteral nutrition.
Prevention steps
Prevention mainly means preventing complications, because many congenital causes cannot be fully prevented after birth. Good steps include early diagnosis, genetic counseling, careful hydration, individualized feeding, strict line care, vaccine review, regular growth checks, vitamin replacement when needed, quick treatment of infection, and close follow-up with pediatric gastroenterology. These actions help prevent severe dehydration, edema, malnutrition, and hospital admission.
When to see doctors urgently
Seek urgent care if there is sunken eyes, extreme sleepiness, fast breathing, no urine, severe swelling, breathing trouble, blood in stool, fever, repeated vomiting, poor feeding, or rapid weight loss. Also seek help if a child on parenteral nutrition gets fever or line redness, because bloodstream infection can become serious very fast.
What to eat and what to avoid
What to eat usually means specialist-directed feeding, not a general internet diet. Helpful choices may include amino-acid or hydrolyzed formula, high-protein intake, medium-chain triglycerides when indicated, vitamin-rich nutrition, and exact replacement of missing minerals. Foods or formulas to avoid may include long-chain fat overload in lymphatic disease, trigger carbohydrates in some transport defects, and any diet change not approved by the child’s specialist. The safest rule is that the diet must match the exact diagnosis.
FAQs
1. Is this one disease? No. It is usually a syndrome pattern with different possible causes.
2. Why is albumin low? Protein leaks from the intestine into the stool.
3. Can it be serious? Yes. It can cause dehydration, swelling, malnutrition, and poor growth.
4. Is nutrition really the main treatment? Yes, in many congenital enteropathies nutrition is the cornerstone of care.
5. Can medicine alone cure it? Often no. Many patients need diet treatment plus cause-specific medical care.
6. Do all patients need parenteral nutrition? No, but some severe cases do.
7. Is a low-fat diet always needed? No. It is most useful in selected cases such as intestinal lymphangiectasia.
8. What is the most advanced drug here? Teduglutide is one of the clearest advanced drugs in short bowel syndrome with parenteral support dependence.
9. Are “immune booster” drugs standard? No. There is no standard immunity-booster drug for this whole condition.
10. Are stem cell drugs standard? No. They are not established routine treatment for this syndrome.
11. Can babies grow normally? Some can do well, especially with early diagnosis and expert nutrition care.
12. Why are vitamins so important? Chronic diarrhea and fat malabsorption can lower many vitamins and minerals.
13. Why are infections a concern? Protein-losing enteropathy can reduce immunoglobulins and lymphocytes.
14. Can surgery cure it? Usually surgery is supportive or used only for special causes or intestinal failure complications.
15. What is the best next step after diagnosis? Work with a pediatric gastroenterology and nutrition team to build a cause-specific plan.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: March 31, 2025.
